PharmAnt is the trusted news hub of the pharma sector

Recent Pharma Sector News

Prostate cancer

Comparing Enzalutamide and Flutamide as First-Line Androgen Therapy for Japanese Men with Castration-Resistant Prostate Cancer: A Clinical Study

Comparing Enzalutamide and Flutamide as First-Line Androgen Therapy for Japanese Men with Castration-Resistant Prostate Cancer: A Clinical Study

1 year ago Mona Al Absi

In 2018, the estimated incidence of prostate cancer was high, with Japan accounting for 6% (78,400 people) of the total...